Testmate Health Revenue and Competitors
Employee Data
- Testmate Health has 11 Employees.
- Testmate Health grew their employee count by -21% last year.
Testmate Health's People
Name | Title | Email/Phone |
---|
Testmate Health Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 59 | 20% | N/A | N/A |
#2 | N/A | 65 | 23% | N/A | N/A |
#3 | N/A | 91 | 26% | N/A | N/A |
#4 | N/A | 295 | 21% | N/A | N/A |
#5 | N/A | 73 | 20% | N/A | N/A |
#6 | N/A | 83 | 34% | N/A | N/A |
#7 | N/A | 55 | 53% | N/A | N/A |
#8 | N/A | 162 | 22% | N/A | N/A |
#9 | N/A | 100 | 22% | N/A | N/A |
#10 | N/A | 61 | 22% | N/A | N/A |
What Is Testmate Health?
Testmate Health is a an early stage healthcare startup focused on low cost, high quality & accurate at home self-testing. Our team brings together expertise in sexual health and diagnostics to bring our mission of making testing for sexual health easy and accessible to life. \n\nSTI rates have soared in recent years, partly due to a reduction in access to easy & affordable testing. Yet, it is asymptomatic in nearly 80% of women, and causes preventable complications during pregnancy and childbirth. Testmate Health is developing the first OTC urine home test for common STIs, that can be performed anywhere, at anytime, providing results in minutes. \n\nTestmate Health raised an over-subscribed Seed Round to accelerate development, and validate their disposable test. \n\nAwards and Accelerators:\n1. MassChallenge Switzerland 2019\n2. HelloTomorrow Top 100 2019\n3. Google For Startups Women's Health 2021\n4. De Vigier Foundation Award 2021\n5. Biopole Startup Award 2022
keywords:N/AN/A
Total Funding
11
Number of Employees
N/A
Revenue (est)
-21%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 11 | 22% | N/A |
#2 | $1M | 11 | -8% | N/A |
#3 | $1.9M | 12 | -64% | N/A |
#4 | $1.1M | 12 | 9% | N/A |
#5 | $1M | 12 | -29% | N/A |